Impact of eligibility criteria discordance on clinical trial accrual in diffuse large B-cell lymphoma (DLBCL).

被引:0
作者
Anderson, Clare E.
Wang, Mei
Wuliji, Natalie
Patel, Anand Ashwin
Lin, Chenyu
机构
[1] Duke Univ, Sch Med, Dept Med, Durham, NC USA
[2] Univ Chicago, Dept Stat, Chicago, IL USA
[3] Fred Hutchinson Canc Ctr, Seattle, WA USA
[4] Univ Chicago, Hematol Oncol Sect, Dept Med, Chicago, IL USA
[5] Duke Univ, Sch Med, Div Hematol Malignancies & Cellular Therapy, Durham, NC USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e13707
引用
收藏
页数:1
相关论文
empty
未找到相关数据